Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,713 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 685
Recruiting: 381
Ph III recruiting: 44
Growth YoY: +8.6%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (277)

clinicaltrialsPublishedShowing 101–115 of 115 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06548178	T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer	not yet recruiting	Phase 2	242	Fudan UniversityOTHER	1	Aug 12, 2024	clinicaltrials
NCT06497322	Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment	not yet recruiting	N/A	60	University Hospital of CologneOTHER	1	Jul 11, 2024	clinicaltrials